Log in

NASDAQ:SNDXSyndax Pharmaceuticals Competitors & Alternatives

$16.85
+1.16 (+7.39 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.10
Now: $16.85
$17.10
50-Day Range
$9.14
MA: $14.97
$20.98
52-Week Range
$5.35
Now: $16.85
$21.97
Volume1.11 million shs
Average Volume605,591 shs
Market Capitalization$608.20 million
P/E RatioN/A
Dividend YieldN/A
Beta1.93

Competitors

Syndax Pharmaceuticals (NASDAQ:SNDX) Competitors and Alternatives

The following companies in the "pharmaceutical preparations" industry are considered alternatives and competitors to Syndax Pharmaceuticals.

Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)
Ra Pharmaceuticals logo
RARX
Ra Pharmaceuticals
0.7$47.99+0.0%$2.27 billion$3 million-20.77
TG Therapeutics logo
TGTX
TG Therapeutics
1.7$20.50+0.4%$2.22 billion$150,000.00-10.10
KRTX
Karuna Therapeutics
1.5$87.97+3.0%$2.16 billionN/A-0.60Analyst Downgrade
Insider Selling
Heavy News Reporting
Principia Biopharma logo
PRNB
Principia Biopharma
1.2$67.88+0.7%$2.15 billion$35.16 million-27.82
Prestige Consumer Healthcare logo
PBH
Prestige Consumer Healthcare
1.6$44.07+4.3%$2.11 billion$963.01 million15.85
TPTX
Turning Point Therapeutics
1.1$65.95+3.2%$2.11 billionN/A-18.32Analyst Report
Insider Buying
SAGE Therapeutics logo
SAGE
SAGE Therapeutics
1.6$37.71+3.6%$2.03 billion$6.87 million-3.03Analyst Report
Epizyme logo
EPZM
Epizyme
1.6$18.84+1.0%$1.98 billion$23.80 million-9.28
Madrigal Pharmaceuticals logo
MDGL
Madrigal Pharmaceuticals
1.6$120.00+0.4%$1.94 billionN/A-17.62
Ironwood Pharmaceuticals logo
IRWD
Ironwood Pharmaceuticals
1.4$10.65+9.9%$1.91 billion$428.41 million20.09High Trading Volume
Heavy News Reporting
Pacira Biosciences logo
PCRX
Pacira Biosciences
1.6$44.65+0.2%$1.84 billion$421.03 million-2,231.38Analyst Report
Aurinia Pharmaceuticals logo
AUPH
Aurinia Pharmaceuticals
1.8$15.94+0.3%$1.82 billion$320,000.00-12.17
Corcept Therapeutics logo
CORT
Corcept Therapeutics
1.3$15.15+3.0%$1.80 billion$306.49 million17.22
Eidos Therapeutics logo
EIDX
Eidos Therapeutics
1.1$48.51+3.9%$1.80 billion$26.69 million-36.75Analyst Upgrade
Xencor logo
XNCR
Xencor
1.4$32.17+0.2%$1.80 billion$156.70 million-30.07
IGMS
IGM Biosciences
1.0$63.30+1.0%$1.78 billionN/A-13.19
Theravance Biopharma logo
TBPH
Theravance Biopharma
1.5$25.11+6.3%$1.73 billion$73.41 million-5.79
ARVN
Arvinas
1.6$42.88+3.6%$1.72 billion$42.98 million-19.40Analyst Downgrade
High Trading Volume
Dicerna Pharmaceuticals logo
DRNA
Dicerna Pharmaceuticals
1.7$20.39+6.7%$1.71 billion$23.90 million-12.07
Heron Therapeutics logo
HRTX
Heron Therapeutics
1.4$19.00+2.9%$1.69 billion$145.97 million-8.37Analyst Report
Zogenix logo
ZGNX
Zogenix
2.2$29.78+1.8%$1.66 billion$3.65 million-3.15
Arcus Biosciences logo
RCUS
Arcus Biosciences
1.4$27.05+24.0%$1.65 billion$15 million-12.52Analyst Report
High Trading Volume
Heavy News Reporting
Zymeworks logo
ZYME
Zymeworks
2.0$39.01+2.1%$1.65 billion$29.54 million-10.03
Ligand Pharmaceuticals logo
LGND
Ligand Pharmaceuticals
1.4$104.77+1.0%$1.61 billion$120.28 million-30.46
Constellation Pharmaceuticals logo
CNST
Constellation Pharmaceuticals
1.4$33.47+3.6%$1.55 billionN/A-11.46Analyst Upgrade
High Trading Volume
Akebia Therapeutics logo
AKBA
Akebia Therapeutics
1.7$12.29+1.1%$1.55 billion$335 million-5.56
Amneal Pharmaceuticals logo
AMRX
Amneal Pharmaceuticals
2.2$4.95+0.4%$1.52 billion$1.63 billion-3.07
Opko Health logo
OPK
Opko Health
2.3$2.29+0.9%$1.51 billion$901.90 million-4.77Analyst Downgrade
Insider Buying
Y-mAbs Therapeutics logo
YMAB
Y-mAbs Therapeutics
1.5$39.14+0.9%$1.50 billionN/A-15.72Insider Selling
Akcea Therapeutics logo
AKCA
Akcea Therapeutics
1.2$15.08+0.9%$1.48 billion$488.54 million-50.27
Intra-Cellular Therapies logo
ITCI
Intra-Cellular Therapies
1.5$22.02+0.1%$1.46 billion$60,000.00-7.92
Innoviva logo
INVA
Innoviva
1.5$14.60+3.1%$1.44 billion$261.02 million8.54
ZNTL
Passage Bio
1.9$41.72+5.0%$1.40 billionN/A0.00
Portola Pharmaceuticals logo
PTLA
Portola Pharmaceuticals
1.5$17.89+0.4%$1.40 billion$116.64 million-4.75
Karyopharm Therapeutics logo
KPTI
Karyopharm Therapeutics
1.8$18.81+2.6%$1.37 billion$40.89 million-6.44Analyst Upgrade
Tricida logo
TCDA
Tricida
1.8$27.03+0.7%$1.36 billionN/A-6.29High Trading Volume
ZEALAND PHARMA/S logo
ZEAL
ZEALAND PHARMA/S
0.8$36.90+2.6%$1.29 billion$6.20 million-13.67High Trading Volume
Supernus Pharmaceuticals logo
SUPN
Supernus Pharmaceuticals
1.8$24.34+2.0%$1.28 billion$392.76 million11.21
Cytokinetics logo
CYTK
Cytokinetics
1.6$21.25+3.1%$1.23 billion$26.87 million-9.49
IMAB
Phoenix Tree
1.0$24.25+5.4%$1.22 billion$4.31 million-0.84Heavy News Reporting
Revance Therapeutics logo
RVNC
Revance Therapeutics
1.7$22.05+2.7%$1.21 billion$410,000.00-5.57
PHAT
Phathom Pharmaceuticals
1.9$43.78+1.1%$1.20 billionN/A-3.13
MacroGenics logo
MGNX
MacroGenics
1.3$23.14+2.2%$1.16 billion$64.19 million-7.49Analyst Report
Arcturus Therapeutics logo
ARCT
Arcturus Therapeutics
0.9$38.56+40.8%$1.16 billion$20.79 million-18.72High Trading Volume
Myovant Sciences logo
MYOV
Myovant Sciences
1.9$12.48+0.6%$1.14 billionN/A-3.70
ARQT
I-Mab
1.6$30.20+0.8%$1.13 billionN/A0.00
Aimmune Therapeutics logo
AIMT
Aimmune Therapeutics
2.4$17.11+0.2%$1.11 billionN/A-3.85Analyst Downgrade
Kiniksa Pharmaceuticals logo
KNSA
Kiniksa Pharmaceuticals
1.2$20.81+4.6%$1.10 billionN/A-9.33
Rocket Pharmaceuticals logo
RCKT
Rocket Pharmaceuticals
2.4$20.02+2.4%$1.10 billionN/A-12.51
Esperion Therapeutics logo
ESPR
Esperion Therapeutics
2.0$39.75+3.5%$1.10 billion$148.36 million-4.13
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.